Callen DF - Search Results

1

Mammary-specific ablation of Cyp24a1 inhibits development, reduces proliferation and increases sensitivity to vitamin D.

Sheng L, Turner AG, Barratt K, Kremer R, Morris HA, Callen DF, Anderson PH, Tarulli GA. Sheng L, et al. Among authors: callen df. J Steroid Biochem Mol Biol. 2019 May;189:240-247. doi: 10.1016/j.jsbmb.2019.01.005. Epub 2019 Jan 14. J Steroid Biochem Mol Biol. 2019. PMID: 30654105

2

Identification of vitamin D₃ target genes in human breast cancer tissue.

Sheng L, Anderson PH, Turner AG, Pishas KI, Dhatrak DJ, Gill PG, Morris HA, Callen DF. Sheng L, et al. Among authors: callen df. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97. doi: 10.1016/j.jsbmb.2015.10.012. Epub 2015 Oct 17. J Steroid Biochem Mol Biol. 2016. PMID: 26485663

3

Vitamin D₃ signaling and breast cancer: Insights from transgenic mouse models.

Sheng L, Callen DF, Turner AG. Sheng L, et al. Among authors: callen df. J Steroid Biochem Mol Biol. 2018 Apr;178:348-353. doi: 10.1016/j.jsbmb.2018.02.006. Epub 2018 Feb 10. J Steroid Biochem Mol Biol. 2018. PMID: 29438722 Review.

4

Systematic characterisation of the rat and human CYP24A1 promoter.

Kumar R, Iachini DN, Neilsen PM, Kaplan J, Michalakas J, Anderson PH, May BK, Morris HA, Callen DF. Kumar R, et al. Among authors: callen df. Mol Cell Endocrinol. 2010 Aug 30;325(1-2):46-53. doi: 10.1016/j.mce.2010.04.023. Epub 2010 May 5. Mol Cell Endocrinol. 2010. PMID: 20450955

5

Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer.

Shakya R, Tarulli GA, Sheng L, Lokman NA, Ricciardelli C, Pishas KI, Selinger CI, Kohonen-Corish MRJ, Cooper WA, Turner AG, Neilsen PM, Callen DF. Shakya R, et al. Among authors: callen df. Oncogene. 2017 Aug;36(31):4469-4480. doi: 10.1038/onc.2017.66. Epub 2017 Apr 3. Oncogene. 2017. PMID: 28368395

6

A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues.

Suetani RJ, Ho K, Jindal S, Manavis J, Neilsen PM, Pishas KI, Rippy E, Bochner M, Kollias J, Gill PG, Morris HA, Callen DF. Suetani RJ, et al. Among authors: callen df. Mol Cell Endocrinol. 2012 Oct 15;362(1-2):202-10. doi: 10.1016/j.mce.2012.06.022. Epub 2012 Jun 29. Mol Cell Endocrinol. 2012. PMID: 22750718

7

New Peptidomimetic Boronates for Selective Inhibition of the Chymotrypsin-like Activity of the 26S Proteasome.

Zhang X, Adwal A, Turner AG, Callen DF, Abell AD. Zhang X, et al. Among authors: callen df. ACS Med Chem Lett. 2016 Sep 13;7(12):1039-1043. doi: 10.1021/acsmedchemlett.6b00217. eCollection 2016 Dec 8. ACS Med Chem Lett. 2016. PMID: 27994734 Free PMC article.

8

ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription.

Kumar R, Manning J, Spendlove HE, Kremmidiotis G, McKirdy R, Lee J, Millband DN, Cheney KM, Stampfer MR, Dwivedi PP, Morris HA, Callen DF. Kumar R, et al. Among authors: callen df. Mol Cancer Res. 2006 Sep;4(9):655-65. doi: 10.1158/1541-7786.MCR-05-0249. Mol Cancer Res. 2006. PMID: 16966434 Free article.

9

The oncogenic role of miR-155 in breast cancer.

Mattiske S, Suetani RJ, Neilsen PM, Callen DF. Mattiske S, et al. Among authors: callen df. Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1236-43. doi: 10.1158/1055-9965.EPI-12-0173. Epub 2012 Jun 26. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22736789 Review.

10

Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.

Hu K, Callen DF, Li J, Zheng H. Hu K, et al. Among authors: callen df. Integr Cancer Ther. 2018 Jun;17(2):217-225. doi: 10.1177/1534735417712007. Epub 2017 Jun 7. Integr Cancer Ther. 2018. PMID: 28589744 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page